Publishing research using ab15260? Please let us know so that we can cite the reference in this datasheet.

ab15260 has been referenced in 1 publication.

  • Gawinecka J  et al. Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis. Neurodegener Dis 9:139-44 (2012). WB ; Human . PubMed: 22213780

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"